CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The cardiac marker testing industry is poised for significant advancements in the near future, driven by breakthroughs in diagnostic technologies and an ...
Alzheimer’s disease is entering a new era of precision care. Disease-modifying drugs are now available that slow brain degeneration, alongside diagnostic tests to enhance early detection and ...
(San Diego, CA) August 21, 2009 – GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this ...
These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...
Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...
Emily Yudofsky (left) and Stefan Bauer (right) personally know the benefits of getting a learning disability diagnosed early. Early diagnosis of learning disabilities in children is vital. Stefan ...
Practice consolidation among U.S. medical oncologists over time. Seroconversion following first and second dose of COVID-19 vaccination among cancer patients: A prospective longitudinal observational ...
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...
Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback